Know Cancer

or
forgot password


N/A
25 Years
85 Years
Open (Enrolling)
Both
Lung Adenocarcinoma

Thank you

Trial Information


Inclusion Criteria:



- We will collect paraffin blocked resected lung tissue samples from stage I~IIIa
non-small cell lung cancer patients (age, 40~80 years old) who received lobectomy of
the affected lung.

Exclusion Criteria:

- History of uremia, other malignant disease, and liver cirrhosis

- History of pneumonia and pulmonary tuberculosis

- History of long period of medications.

Type of Study:

Observational

Study Design:

Time Perspective: Retrospective

Authority:

Taiwan: Institutional Review Board

Study ID:

DMR99-IRB-062

NCT ID:

NCT01249053

Start Date:

August 2010

Completion Date:

Related Keywords:

  • Lung Adenocarcinoma
  • OPA1
  • lung adenocarcinomas
  • Prognosis
  • Expression of optic atrophy type 1 (OPA1) protein in lung adenocarcinoma
  • Adenocarcinoma
  • Adenocarcinoma, Mucinous
  • Optic Atrophy
  • Lung Neoplasms
  • Optic Atrophy, Autosomal Dominant

Name

Location